These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8791478)

  • 1. Hereditary predisposition to breast cancer.
    Stratton MR; Wooster R
    Curr Opin Genet Dev; 1996 Feb; 6(1):93-7. PubMed ID: 8791478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes.
    Vehmanen P; Friedman LS; Eerola H; McClure M; Ward B; Sarantaus L; Kainu T; Syrjäkoski K; Pyrhönen S; Kallioniemi OP; Muhonen T; Luce M; Frank TS; Nevanlinna H
    Hum Mol Genet; 1997 Dec; 6(13):2309-15. PubMed ID: 9361038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRCA1 and BRCA2 genes: role in hereditary breast and ovarian cancer in Italy.
    Santarosa M; Dolcetti R; Magri MD; Crivellari D; Tibiletti MG; Gallo A; Tumolo S; Della Puppa L; Furlan D; Boiocchi M; Viel A
    Int J Cancer; 1999 Sep; 83(1):5-9. PubMed ID: 10449599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes?
    Serova OM; Mazoyer S; Puget N; Dubois V; Tonin P; Shugart YY; Goldgar D; Narod SA; Lynch HT; Lenoir GM
    Am J Hum Genet; 1997 Mar; 60(3):486-95. PubMed ID: 9042907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA1 and BRCA2 in breast cancer.
    Yang X; Lippman ME
    Breast Cancer Res Treat; 1999 Mar; 54(1):1-10. PubMed ID: 10369075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Mutations in brief no. 178. Online.
    De Benedetti VM; Radice P; Pasini B; Stagi L; Pensotti V; Mondini P; Manoukian S; Conti A; Spatti G; Rilke F; Pierotti MA
    Hum Mutat; 1998; 12(3):215. PubMed ID: 10660329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients.
    Yazici H; Bitisik O; Akisik E; Cabioglu N; Saip P; Muslumanoglu M; Glendon G; Bengisu E; Ozbilen S; Dincer M; Turkmen S; Andrulis IL; Dalay N; Ozcelik H
    Br J Cancer; 2000 Sep; 83(6):737-42. PubMed ID: 10952777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease. Mutations in brief no. 224. Online.
    Claes K; Machackova E; De Vos M; Mortier G; De Paepe A; Messiaen L
    Hum Mutat; 1999; 13(3):256. PubMed ID: 10090482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage.
    Marcus JN; Watson P; Page DL; Narod SA; Lenoir GM; Tonin P; Linder-Stephenson L; Salerno G; Conway TA; Lynch HT
    Cancer; 1996 Feb; 77(4):697-709. PubMed ID: 8616762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2.
    Rebbeck TR; Couch FJ; Kant J; Calzone K; DeShano M; Peng Y; Chen K; Garber JE; Weber BL
    Am J Hum Genet; 1996 Sep; 59(3):547-53. PubMed ID: 8751855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families.
    Stadler ZK; Saloustros E; Hansen NA; Schluger AE; Kauff ND; Offit K; Robson ME
    Breast Cancer Res Treat; 2010 Sep; 123(2):581-5. PubMed ID: 20221693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families.
    Ikeda N; Miyoshi Y; Yoneda K; Shiba E; Sekihara Y; Kinoshita M; Noguchi S
    Int J Cancer; 2001 Jan; 91(1):83-8. PubMed ID: 11149425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
    Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
    Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
    Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L
    Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inherited breast cancer: an emerging picture.
    Welcsh PL; Schubert EL; King MC
    Clin Genet; 1998 Dec; 54(6):447-58. PubMed ID: 9894790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in understanding of genetic susceptibility to breast cancer.
    Stratton MR
    Hum Mol Genet; 1996; 5 Spec No():1515-9. PubMed ID: 8875258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High throughput fluorescence-based conformation-sensitive gel electrophoresis (F-CSGE) identifies six unique BRCA2 mutations and an overall low incidence of BRCA2 mutations in high-risk BRCA1-negative breast cancer families.
    Ganguly T; Dhulipala R; Godmilow L; Ganguly A
    Hum Genet; 1998 May; 102(5):549-56. PubMed ID: 9654203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRCA2 germline mutations in male breast cancer cases and breast cancer families.
    Couch FJ; Farid LM; DeShano ML; Tavtigian SV; Calzone K; Campeau L; Peng Y; Bogden B; Chen Q; Neuhausen S; Shattuck-Eidens D; Godwin AK; Daly M; Radford DM; Sedlacek S; Rommens J; Simard J; Garber J; Merajver S; Weber BL
    Nat Genet; 1996 May; 13(1):123-5. PubMed ID: 8673091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic susceptibility to breast and ovarian cancer.
    Skolnick MH; Frank T; Shattuck-Eidens D; Tavtigian S
    Pathol Biol (Paris); 1997 Mar; 45(3):245-9. PubMed ID: 9296070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation analysis of BRCA1 and BRCA2 in Turkish cancer families: a novel mutation BRCA2 3414del4 found in male breast cancer.
    Balci A; Huusko P; Pääkkönen K; Launonen V; Uner A; Ekmekçi A; Winqvist R
    Eur J Cancer; 1999 May; 35(5):707-10. PubMed ID: 10505028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.